⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
ALT-006150Pre-approval
AI-ECG Guided Care (SmartECG-AFrisk)
Yonsei University · Sponsor
Regulatory Pipeline
1
Proof of Concept2
Development3
Clinical Trial4
Pre-submission5
Submitted6
Under Review7
ClearedAll identifiers (2)
Aletia (canonical)
ALT-006150ClinicalTrials.gov (primary)
NCT07173673Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Yonsei University, you can claim this listing to add funding, team, and contact details.
Claim this listing →Clinical Trial Signal
NCT07173673 ↗
unknown
A Prospective, Multi-center, Randomized Clinical Trial to Evaluate the Detection of Atrial Fibrillation Using Artificial Intelligence-Enhanced Electrocardiography (SmartECG-AFrisk) Compared With Usual Care in Patients With Suspected Atrial Fibrillation: DEEP-AF
Phase: na1230 enrolledKR
Investor Interest
Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.
0
investors